← Back to Search

Sound Amplification Device

Personal sound amplification products for Age-Related Hearing Loss

N/A
Waitlist Available
Led By Claude Alain, PhD
Research Sponsored by Rotman Research Institute at Baycrest
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Right-handed
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours
Awards & highlights

Study Summary

This trial will study the neurobiological and behavioral effects of using personal sound amplification devices (PSAPs) to improve speech perception in noise for people with mild to moderate hearing loss.

Eligible Conditions
  • Age-Related Hearing Loss

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in EEG measure of connectivity strength with and without PSAPs
Difference in EEG measure of wave amplitude with and without PSAPs
Difference in EEG measure of wave latency with and without PSAPs
+5 more
Secondary outcome measures
Difference in self-reported measure of listening effort with and without PSAPs

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personal sound amplification productsExperimental Treatment1 Intervention
Speech perception will be evaluated using personal sound amplification products.
Group II: ControlActive Control1 Intervention
Speech perception will be evaluated without using hearing devices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personal sound amplification products
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Rotman Research Institute at BaycrestLead Sponsor
10 Previous Clinical Trials
430 Total Patients Enrolled
Claude Alain, PhDPrincipal InvestigatorRotman Research Institute at Baycrest Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effects of PSAPs on Speech Processing
Claude Alain 2022. "Effects of PSAPs on Speech Processing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05076045.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top